Microscopic medicines unlock new treatments for MND and Alzheimer’s
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Jun-2026 18:17 ET (3-Jun-2026 22:17 GMT/UTC)
New treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and motor neurone disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University of Essex. Using artificial intelligence, an international team of scientists has created tiny antibody fragments that can be made directly inside human cells, where they bind to proteins linked to disease. These redesigned molecules will be made freely available to other scientists now the research has been published in Nature Communications.
Experiencing a sense of loss and sadness after dozens of hours spent on a video game? Researchers from SWPS University and the Stefan Batory Academy of Applied Sciences examined the feeling of emptiness that accompanies completing an engaging computer game. They created the world's first scale for measuring post-game depression, and published their research results in the international journal Current Psychology.
Ageing is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age – a valuable tool for research on ageing and the development of new approaches in preventive medicine.
Lawrence Toll, Ph.D., has been named a senior member of the National Academy of Inventors, recognizing his impactful patented innovations. Honored for pioneering neuropharmacology research, his work has identified novel drug targets in opioid, nociceptin and nicotinic systems, including co-discovery of nociceptin. His decades of research, publications and patents have advanced safer pain therapies and new treatments for substance use disorders.
The World Institute of Kimchi (President: Hae Choon Chang), a government-funded research institute under the Ministry of Science and ICT, announced that a lactic acid bacterium isolated from kimchi can help promote the removal of nanoplastics from the body by binding to them in the intestine.
Los Angeles, CA. — March 19, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) and UCLA Technology Development Group (TDG) announced today a collaboration to program the Advanced Organ and Tissue Repair session during MedTech Day at LABEST, one of Southern California’s premier innovation conferences.